Jim Simons Cocrystal Pharma, Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
 - Q2 2025
 
Shares
	  13 transactions
	
  About Cocrystal Pharma, Inc.
- Ticker COCP
 - Exchange NASDAQ
 - Sector Healthcare
 - Industry Biotechnology
 - Shares Outstandng 8,122,420
 - Market Cap $8.85M
 - Description
 - Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...